|
|
|
|
|
|
|
|
|
|
Blogger's Note: note references to darbepoetin alfa/cancer
Article
Conclusions
Treatment with darbepoetin alfa did not improve clinical outcomes in patients with systolic heart failure and mild-to-moderate anemia. Our findings do not support the use of darbepoetin alfa in these patients. (Funded by Amgen; RED-HF ClinicalTrials.gov number, NCT00358215.)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.